Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Affiliations

• ¹ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
• ² Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
• ³ Health, Innovation and Research Institute (Clinical Trial Unit), University Hospital Ghent, Ghent, Belgium.
• ⁴ National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
• ⁵ Department of Urology, University Hospital Ghent, Ghent, Belgium.
• ⁶ Department of Oncology, Capio Saint Göran's Hospital, Stockholm, Sweden.
• ⁷ Department of Oncology, Länssjukhuset Ryhov, Jönköping, Sweden.
• ⁸ Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
• ⁹ Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
• ¹⁰ Department of Oncology, University Hospital of Umeå, Umeå, Sweden.
• ¹¹ Department of Oncology, Sundsvalls sjukhus, Sundsvall, Sweden.
• ¹² Department of Oncology, Centralsjukhuset Karlstad, Karlstad, Sweden.
• ¹³ Department of Urology, Onze Lieve Vrouwziekenhuis, Aalst, Belgium.
• ¹⁴ Department of Oncology, Stavanger University Hospital, Stavanger, Norway.
• ¹⁵ Department of Oncology, Centrallasarettet Växjö, Växjö, Sweden.
• ¹⁶ Department of Urology, AZ Sint Jan Brugge AV, Bruges, Belgium.
• ¹⁷ Department of Oncology, CHU de Liège - site Sart Tilman, Liège, Belgium.
• ¹⁸ Department of Oncology, Ziekenhuis Oost- Limburg, Genk, Belgium.
• ¹⁹ Department of Urology, AZ Groeninge, Kortrijk, Belgium.
• ²⁰ Department of Oncology, Länssjukhuset i Kalmar, Kalmar, Sweden.
• ²¹ Department of Oncology, Falu lasarett, Falu, Sweden.
• ²² Department of Oncology, AZ Sint-Lucas, Bruges, Belgium.
• ²³ Department of Oncology, Vitaz campus Sint-Niklaas Lodewijk, Sint-Niklaas, Belgium.
• ²⁴ Department of Urology, AZ Damiaan, Oostende, Belgium.
• ²⁵ Department of Oncology, Ålesund Hospital, Ålesund, Norway.
• ²⁶ Department of Oncology, Virga Jessa, Hasselt, Belgium.
• ²⁷ Department of Oncology, GZA Sint-Augustinus, Antwerpen, Belgium.
• ²⁸ Department of Urology, Universitätsspital Basel, Basel, Switzerland.
• ²⁹ Department of Urology, Universitätsspital Zürich, Zürich, Switzerland.
• ³⁰ Department of Oncology, Akershus University Hospital, Nordbyhagen, Norway.
• ³¹ Department of Radiation Oncology, GZA Sint-Augustinus, Antwerpen, Belgium.
• ³² Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. henrik.gronberg@ki.se.
• ³³ Prostatacancer Centrum, Capio S:t Görans Sjukhus, Stockholm, Sweden. henrik.gronberg@ki.se.
• ³⁴ Department of Medical Epidemiology and Biostatistics, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.